Triple i (a MediMedia Company) Selects IBM Cognos Business Intelligence Solutions.

~ Triple i to incorporate IBM Cognos 8 Business Intelligence within Triple i solutions for the development of customized pharmaceutical marketing strategies ~

CHATHAM, N.J. -- Triple i, a MediMedia company and innovative pharmaceutical marketing provider, announced an OEM agreement with Cognos,

Triple i will incorporate IBM Cognos 8 BI reporting and analysis capabilities into its integrated approach to pharmaceutical promotion, providing their clients a complete, consistent view of information and a solid foundation for improved decision-making. IBM Cognos 8 BI brings the power of reporting, analysis, scorecarding, dashboards, and business event management to Triple i. Triple i's integrated solutions, powered by Cognos, will enable marketers to effectively communicate and impact their targeted audiences.

"The addition of Cognos will enable Triple i to offer customers a customized integrated marketing strategy that best matches tactics and resources with customer requirements and marketplace realities," said Ted Jandl, Cognos vice president of global OEM partners. "We are excited to have Triple i as one of our OEM partners and look forward to working with them on new and innovative pharmaceutical marketing solutions."

"The changing requirements faced by pharmaceutical companies have resulted in an evolution of the industry's promotional model," said Tom Langan, president of Triple i. "The implementation of Cognos will enable Triple i to address their customers' need for innovative marketing tactics and tools. By converting data into knowledge then action, our marketing programs that we manage for our clients will be enhanced and their impact magnified."

About MediMedia

Headquartered in Chatham, NJ, with over 1,600 employees in offices throughout the U.S. MediMedia's products and services include integrated and comprehensive health management programs, patient education content, and applications purchased by healthcare stakeholders: physicians, patients, employers, hospitals, health plans and pharmaceutical companies. MediMedia's pharmaceutical marketing group provides solutions for pharmaceutical companies along their entire marketing continuum, targeting physicians and patients with superior content and applications. MediMedia's experience in delivering specialized information to targeted audiences has earned MediMedia unparalleled trust and respect throughout the industry.

For more information, please visit www.medimedia.com or www.tripleimedimedia.com.

MediMedia is a Vestar Capital Partners portfolio company.